NTA Survey of Taxi’s and Hackneys

July 7th, 2021

The National Transport Authority (NTA) is committed to the provision of high quality, accessible, sustainable transport connecting people across Ireland. In furtherance of this aim NTA has engaged Behaviour & Attitudes, an independent market research company based in Dublin, to conduct this survey with the aim of getting information on the demand, delivery and accessibility levels of small public service vehicle (SPSV) passenger services nationwide, for example taxis and hackneys. The data obtained through this survey will assist NTA in enhancing the SPSV passenger services strategy.

The survey can be completed in the following ways:

  1. Online, via the following link which is compatible with screen-readers: https://secure.bandasurvey.ie/WebProd/Start/Ba212691
  1. By post: if you require a hard-copy version of the survey, please contact Behaviour & Attitudes at glenn@banda.ie You will also receive a stamped addressed envelope to facilitate the return of your completed survey.
  1. By telephone: should you prefer to complete the survey in this manner, please contact Behaviour & Attitudes at glenn@banda.ie  or on 01 2057561.They will arrange for an agent to call you to go through the questions with you.

Should you wish, you may also ask someone to complete the survey on your behalf.

The survey, which is voluntary, will close on Friday 30th July 2021 at 5pm and responses received after this date will not be considered. All responses will be anonymised and the survey findings will be presented in a grouped format

Finally NTA would like to thank you for taking the time to complete the survey. Your assistance is greatly appreciated

Share Now:

Categories: News

1. Muscular Dystrophies

  • Becker muscular dystrophy
  • Duchenne muscular dystrophy
  • Manifesting carrier of Duchenne
  • Congenital muscular dystrophy
  •     •  General
  •     •  MDC1A (merosin-deficient congenital muscular dystrophy)
  •     •  Rigid spine syndrome (RSS)
  •     •  Ullrich congenital muscular dystrophies
  •     •  Bethlem myopathy
  • Emery-Dreifuss muscular dystrophy
  • Facioscapulohumeral muscular dystrophy
  • Limb-girdle types of muscular dystrophy (LGMD)
  •     •  General
  •     •  LGMD 1B (also known as Laminopathy)
  •     •  LGMD 1C (also known as Caveolinopathy)
  •     •  LGMD 2A (also known as Calpainopathy)
  •     •  LGMD 2B (also known as Dysferlinopathy)
  •     •  LGMD 2I
  • Ocular myopathies including ocularopharangeal muscular dystrophy

2. Myotonic Disorders

  • Congenital Myotonic Dystrophy
  • Myotonia
  • Myotonic Dystrophy

3. Congenital Myopathies

  • Central Core Myopathy
  • Congenital Fibre-type Disproportion Myopathy
  • Minicore (Multicore) myopathy
  • Myotubular or Centronuclear myopathy
  • Nemaline myopathy

4. Mitochondrial Myopathies

  • Mitochondrial Myopathies

5. Metabolic Disorders

  • Metabolic disorders (general)
  • McArdle’s Disease
  • Pompe’s Disease

6. Periodic Paralyses

  • Periodic Paralyses

7. Autoimmune Myositis

  • Polymyositis, Dermatomyositis and Sarcoid myopathy
  • Juvenile dermatomyositis
  • Inclusion body myositis

8. Spinal Muscular Atrophies

  • Severe (Type I)
  • Intermediate (Type II)
  • Mild (Type III)
  • Adult spinal muscular atrophy

9. Hereditary Motor and Sensory Neuropathies

  • (Also known as Charcot-Marie-Tooth or Peroneal muscular atrophy)

10. Disorders of the Neuromuscular Junction

  • Congenital myasthenic syndromes
  • Myasthenia Gravis

11. Friedreich’s Ataxia

  • Friedreich’s Ataxia

12. Other (Please Specify)

13. Unspecified